Hepatitis A Vaccine (Human Diploid Cell), Inactivated – Healive^®

Launched in 2002

Hepatitis A & Hepatitis B Combined Vaccine – Bilive^®

Launched in 2005

Healive^® :

• Prequalified by the World Health Organization.

• Provides sustained immune protection for at least 30 years after full immunization, according to model predictions.

• Exhibits good safety and can be administrated to people with unerlying medical conditions.

• Has been exported to more than 40 countries and regions, and used in many countries as part of the National Immunization Program.

Bilive, the Hepatitis A & Hepatitis B Combined Vaccine, was launched in 2005, employing the same manufacturing technology as Healive^® offering dual protection against both hepatitis A and hepatitis B.